Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jean-François Brepson | M | - |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Christiane Honisch | M | - |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | 6 jaar |
Arne C. Faisst | M | - |
4D Lifetec AG
4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 jaar |
Nick Mijnssen | M | - |
4D Lifetec AG
4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 10 jaar |
Thierry Laugel | M | 57 |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Jean-Pascal Beaufret | M | 73 |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Marco Zingg | M | - |
4D Lifetec AG
4D Lifetec AG BiotechnologyHealth Technology 4D Lifetec AG is a Swiss startup that specializes in developing the 4D Lifetest™, a liquid biopsy assay for the early detection of cancer. The company is based in Cham, Switzerland. The Swiss company's products for genotox applications are already commercially available, and they are currently working on future products for Integral Liquid Biopsy. The company's vision is to establish a test system for effective early cancer diagnostics and create a door opener to cancer prediction. The company was founded in 2014 by Nick Mijnssen. Arne C. Faisst has been the CEO of the company since 2014. | 5 jaar |
Laurent Lafferrère | M | - |
PathoQuest SAS
PathoQuest SAS Medical SpecialtiesHealth Technology PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Frankrijk | 5 | 62.50% |
Zwitserland | 3 | 37.50% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Rainer Metzger
- Persoonlijk netwerk